|
|
integrin biosynthetic process
|
GO:0045112 |
1 |
0.987
|
Mouse |
|
|
positive regulation of myeloid cell apoptotic process
|
GO:0033034 |
4 |
0.972
|
|
|
|
membrane raft assembly
|
GO:0001765 |
3 |
0.969
|
|
|
|
regulation of neutrophil apoptotic process
|
GO:0033029 |
1 |
0.951
|
|
|
|
positive regulation of neutrophil apoptotic process
|
GO:0033031 |
1 |
0.950
|
|
|
|
positive regulation of peptide secretion
|
GO:0002793 |
33 |
0.881
|
Mouse |
|
|
membrane organization
|
GO:0061024 |
245 |
0.869
|
Mouse |
|
|
positive regulation of vesicle fusion
|
GO:0031340 |
2 |
0.833
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.808
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.804
|
Mouse |
|
|
actin cytoskeleton reorganization
|
GO:0031532 |
21 |
0.801
|
Mouse |
|
|
regulation of immunological synapse formation
|
GO:2000520 |
2 |
0.775
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.769
|
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.727
|
Mouse |
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.718
|
Mouse |
|
|
fibrinolysis
|
GO:0042730 |
3 |
0.707
|
|
|
|
regulation of neuronal synaptic plasticity
|
GO:0048168 |
30 |
0.704
|
Mouse |
|
|
neutrophil apoptotic process
|
GO:0001781 |
3 |
0.702
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.696
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.672
|
|
|
|
regulation of integrin biosynthetic process
|
GO:0045113 |
1 |
0.642
|
Mouse |
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.620
|
Mouse |
|
|
regulation of binding
|
GO:0051098 |
111 |
0.614
|
Mouse |
|
|
cell chemotaxis
|
GO:0060326 |
81 |
0.612
|
Mouse |
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.591
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.587
|
Mouse |
|
|
long chain fatty acid transport
|
GO:0015909 |
15 |
0.569
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.521
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.519
|
|
|
|
negative regulation of immunological synapse formation
|
GO:2000521 |
1 |
0.517
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.441
|
Mouse |
|
|
amide transport
|
GO:0042886 |
138 |
0.434
|
Mouse |
|
|
angiogenesis
|
GO:0001525 |
201 |
0.431
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.421
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.417
|
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.415
|
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.412
|
Mouse |
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.400
|
Mouse |
|
|
regulation of calcium ion transport
|
GO:0051924 |
69 |
0.396
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.380
|
|
|
|
response to calcium ion
|
GO:0051592 |
20 |
0.369
|
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.363
|
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.353
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.344
|
Mouse |
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
57 |
0.339
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.337
|
Mouse |
|
|
organic acid transport
|
GO:0015849 |
101 |
0.322
|
|
|
|
plasma cell differentiation
|
GO:0002317 |
3 |
0.321
|
|
|
|
membrane fusion
|
GO:0061025 |
38 |
0.317
|
|
|
|
protein heterotetramerization
|
GO:0051290 |
4 |
0.313
|
|
|
|
leukocyte chemotaxis
|
GO:0030595 |
69 |
0.310
|
Mouse |
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.309
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.304
|
Mouse |
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.292
|
|
|
|
inflammatory cell apoptotic process
|
GO:0006925 |
11 |
0.291
|
|
|
|
membrane biogenesis
|
GO:0044091 |
12 |
0.278
|
|
|
|
antigen receptor mediated signaling pathway
|
GO:0050851 |
64 |
0.271
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.268
|
|
|
|
muscle system process
|
GO:0003012 |
141 |
0.262
|
|
|
|
engulfment of apoptotic cell
|
GO:0043652 |
3 |
0.260
|
|
|
|
mature b cell differentiation involved in immune response
|
GO:0002313 |
9 |
0.248
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.246
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.245
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.243
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.238
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.238
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.237
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.235
|
|
|
|
vesicle organization
|
GO:0016050 |
60 |
0.230
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.220
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.218
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.218
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.209
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.200
|
|
|
|
myeloid cell apoptotic process
|
GO:0033028 |
22 |
0.199
|
|
|
|
memory
|
GO:0007613 |
58 |
0.197
|
Mouse |
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.191
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.185
|
Mouse |
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.181
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.180
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.176
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.175
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.171
|
Mouse |
|
|
immune effector process
|
GO:0002252 |
321 |
0.171
|
|
|
|
arachidonic acid secretion
|
GO:0050482 |
8 |
0.168
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.166
|
Mouse |
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.162
|
|
|
|
fatty acid transport
|
GO:0015908 |
28 |
0.157
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.157
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.155
|
Mouse |
|
|
positive regulation of g1 s transition of mitotic cell cycle
|
GO:1900087 |
9 |
0.154
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.153
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.152
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.152
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.150
|
|
|
|
lymphocyte costimulation
|
GO:0031294 |
15 |
0.147
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.146
|
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.144
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.142
|
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.141
|
|
|
|
membrane assembly
|
GO:0071709 |
12 |
0.141
|
|
|
|
icosanoid secretion
|
GO:0032309 |
12 |
0.139
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.138
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.136
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.135
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.133
|
|
|
|
positive regulation of leukocyte apoptotic process
|
GO:2000108 |
21 |
0.133
|
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.133
|
|
|
|
cellular response to antibiotic
|
GO:0071236 |
4 |
0.129
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.129
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.129
|
|
|
|
cell cell recognition
|
GO:0009988 |
44 |
0.129
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.127
|
|
|
|
negative regulation of interleukin 8 secretion
|
GO:2000483 |
1 |
0.127
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.119
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.114
|
|
|
|
icosanoid transport
|
GO:0071715 |
14 |
0.114
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.110
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.110
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.110
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.109
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.107
|
|
|
|
negative regulation of t cell activation via t cell receptor contact with antigen bound to mhc molecule on antigen presenting cell
|
GO:2001189 |
1 |
0.107
|
|
|
|
positive regulation of mitotic cell cycle phase transition
|
GO:1901992 |
17 |
0.103
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.103
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.101
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.099
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.097
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.096
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.096
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.095
|
|
|
|
regulation of substrate adhesion dependent cell spreading
|
GO:1900024 |
12 |
0.094
|
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.093
|
Mouse |
|
|
peptide secretion
|
GO:0002790 |
114 |
0.093
|
Mouse |
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.092
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.091
|
|
|
|
fatty acid derivative transport
|
GO:1901571 |
14 |
0.090
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.089
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.088
|
|
|
|
regulation of integrin mediated signaling pathway
|
GO:2001044 |
8 |
0.088
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.086
|
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.086
|
|
|
|
regulation of antigen receptor mediated signaling pathway
|
GO:0050854 |
29 |
0.085
|
|
|
|
establishment of protein localization to plasma membrane
|
GO:0090002 |
34 |
0.084
|
|
|
|
negative regulation of wound healing
|
GO:0061045 |
14 |
0.084
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.083
|
|
|
|
positive regulation of rac gtpase activity
|
GO:0032855 |
14 |
0.083
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.082
|
|
|
|
cellular water homeostasis
|
GO:0009992 |
2 |
0.081
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.080
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
57 |
0.079
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.078
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.078
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.076
|
|
|
|
interleukin 8 production
|
GO:0032637 |
4 |
0.075
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.075
|
|
|
|
t cell activation via t cell receptor contact with antigen bound to mhc molecule on antigen presenting cell
|
GO:0002291 |
2 |
0.075
|
|
|
|
membrane raft organization
|
GO:0031579 |
5 |
0.073
|
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.072
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.072
|
|
|
|
coagulation
|
GO:0050817 |
78 |
0.071
|
|
|
|
myotube cell development
|
GO:0014904 |
60 |
0.070
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.069
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.069
|
|
|
|
negative regulation of endocytosis
|
GO:0045806 |
12 |
0.069
|
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.068
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.068
|
|
|
|
eosinophil migration
|
GO:0072677 |
3 |
0.068
|
|
|
|
acetylcholine transport
|
GO:0015870 |
2 |
0.067
|
|
|
|
learning or memory
|
GO:0007611 |
148 |
0.067
|
Mouse |
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.067
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.067
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.066
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.066
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.065
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.065
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.064
|
|
|
|
organelle fusion
|
GO:0048284 |
28 |
0.063
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.062
|
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.062
|
|
|
|
intestinal absorption
|
GO:0050892 |
13 |
0.061
|
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.061
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.060
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.060
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.059
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.058
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.057
|
|
|
|
leukocyte apoptotic process
|
GO:0071887 |
71 |
0.057
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.057
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.056
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.056
|
|
|
|
positive regulation of substrate adhesion dependent cell spreading
|
GO:1900026 |
8 |
0.055
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.055
|
|
|
|
myotube differentiation
|
GO:0014902 |
105 |
0.054
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.054
|
|
|
|
regulation of voltage gated calcium channel activity
|
GO:1901385 |
4 |
0.053
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.053
|
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.052
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.052
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.052
|
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.052
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.051
|
|
|
|
acetylcholine secretion neurotransmission
|
GO:0014055 |
2 |
0.051
|
|
|
|
regulation of blood circulation
|
GO:1903522 |
93 |
0.051
|
|
|
|
negative regulation of hemostasis
|
GO:1900047 |
11 |
0.050
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.048
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.048
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.048
|
|
|
|
cell volume homeostasis
|
GO:0006884 |
9 |
0.047
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.047
|
|
|
|
positive regulation of cell cycle phase transition
|
GO:1901989 |
17 |
0.047
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.046
|
|
|
|
negative regulation of interleukin 8 production
|
GO:0032717 |
1 |
0.046
|
|
|
|
response to muscle stretch
|
GO:0035994 |
1 |
0.045
|
|
|
|
immune response activating cell surface receptor signaling pathway
|
GO:0002429 |
72 |
0.044
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.044
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.044
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.044
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.044
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.043
|
|
|
|
regulation of interleukin 8 production
|
GO:0032677 |
3 |
0.043
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.043
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.043
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.042
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.042
|
Rat |
|
|
t cell mediated cytotoxicity
|
GO:0001913 |
26 |
0.041
|
|
|
|
sensory system development
|
GO:0048880 |
3 |
0.041
|
|
|
|
negative regulation of immune effector process
|
GO:0002698 |
55 |
0.040
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.040
|
|
|
|
cellular response to hepatocyte growth factor stimulus
|
GO:0035729 |
2 |
0.040
|
|
|
|
cytokine secretion
|
GO:0050663 |
72 |
0.040
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
57 |
0.040
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.040
|
Mouse |
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.040
|
|
|
|
immunological synapse formation
|
GO:0001771 |
7 |
0.040
|
|
|
|
thymocyte migration
|
GO:0072679 |
2 |
0.040
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.040
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.039
|
|
|
|
positive regulation of wound healing
|
GO:0090303 |
17 |
0.039
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.039
|
|
|
|
transmission of nerve impulse
|
GO:0019226 |
76 |
0.039
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.039
|
|
|
|
multi organism behavior
|
GO:0051705 |
62 |
0.038
|
|
|
|
cardiac muscle contraction
|
GO:0060048 |
32 |
0.038
|
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.038
|
|
|
|
vesicle fusion
|
GO:0006906 |
16 |
0.037
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.037
|
|
|
|
leukocyte homeostasis
|
GO:0001776 |
79 |
0.037
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.036
|
|
|
|
prostate gland stromal morphogenesis
|
GO:0060741 |
2 |
0.036
|
|
|
|
t cell costimulation
|
GO:0031295 |
14 |
0.036
|
|
|
|
focal adhesion assembly
|
GO:0048041 |
19 |
0.036
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.036
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.036
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.036
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.036
|
|
|
|
response to osmotic stress
|
GO:0006970 |
21 |
0.035
|
|
|
|
detection of muscle stretch
|
GO:0035995 |
1 |
0.035
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.035
|
|
|
|
t cell mediated immunity
|
GO:0002456 |
50 |
0.034
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.034
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.034
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.033
|
|
|
|
maintenance of epithelial cell apical basal polarity
|
GO:0045199 |
2 |
0.033
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.033
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.033
|
|
|
|
regulation of leukocyte apoptotic process
|
GO:2000106 |
56 |
0.032
|
|
|
|
regulation of heart rate by chemical signal
|
GO:0003062 |
4 |
0.032
|
|
|
|
positive regulation of cell cycle g1 s phase transition
|
GO:1902808 |
9 |
0.032
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.032
|
|
|
|
cell recognition
|
GO:0008037 |
83 |
0.032
|
|
|
|
regulation of actin filament length
|
GO:0030832 |
45 |
0.032
|
|
|
|
protein kinase c signaling
|
GO:0070528 |
7 |
0.032
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.032
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
77 |
0.031
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.031
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.031
|
|
|
|
neutrophil homeostasis
|
GO:0001780 |
7 |
0.031
|
|
|
|
protein tetramerization
|
GO:0051262 |
23 |
0.031
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.030
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.030
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.030
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.029
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.029
|
|
|
|
apoptotic cell clearance
|
GO:0043277 |
17 |
0.029
|
|
|
|
positive regulation of cell motility
|
GO:2000147 |
116 |
0.029
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.029
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.029
|
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.029
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.029
|
|
|
|
mature b cell differentiation
|
GO:0002335 |
13 |
0.029
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.028
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.028
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.028
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
34 |
0.028
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.028
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.028
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.028
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.028
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.028
|
|
|
|
negative regulation of blood coagulation
|
GO:0030195 |
11 |
0.028
|
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.028
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
91 |
0.028
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.027
|
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.027
|
|
|
|
skeletal muscle fiber development
|
GO:0048741 |
58 |
0.027
|
|
|
|
immune response activating signal transduction
|
GO:0002757 |
116 |
0.027
|
|
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.027
|
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.027
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.027
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.027
|
|
|
|
multicellular organismal signaling
|
GO:0035637 |
91 |
0.027
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.026
|
|
|
|
chloride transmembrane transport
|
GO:1902476 |
24 |
0.026
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.026
|
|
|
|
prostate gland development
|
GO:0030850 |
48 |
0.026
|
|
|
|
cellular response to calcium ion
|
GO:0071277 |
14 |
0.026
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.026
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.026
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.026
|
|
|
|
t cell apoptotic process
|
GO:0070231 |
39 |
0.025
|
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.025
|
|
|
|
early endosome to late endosome transport
|
GO:0045022 |
2 |
0.025
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.025
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.024
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
48 |
0.024
|
|
|
|
nuclear membrane organization
|
GO:0071763 |
4 |
0.024
|
|
|
|
cellular response to light stimulus
|
GO:0071482 |
19 |
0.024
|
|
|
|
cellular response to toxic substance
|
GO:0097237 |
7 |
0.024
|
|
|
|
positive regulation of integrin mediated signaling pathway
|
GO:2001046 |
5 |
0.024
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.024
|
|
|
|
positive regulation of necrotic cell death
|
GO:0010940 |
1 |
0.024
|
|
|
|
lateral line system development
|
GO:0048925 |
1 |
0.024
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.024
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.024
|
|
|
|
regulation of lamellipodium morphogenesis
|
GO:2000392 |
1 |
0.024
|
|
|
|
protein localization to nuclear envelope
|
GO:0090435 |
2 |
0.023
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.023
|
|
|
|
negative regulation of phagocytosis
|
GO:0050765 |
4 |
0.023
|
|
|
|
positive regulation of ion transport
|
GO:0043270 |
65 |
0.023
|
|
|
|
cytosolic calcium ion transport
|
GO:0060401 |
48 |
0.023
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.023
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.023
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.023
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.023
|
|
|
|
action potential
|
GO:0001508 |
78 |
0.023
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.023
|
|
|
|
neutrophil degranulation
|
GO:0043312 |
6 |
0.022
|
|
|
|
regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
GO:1902041 |
22 |
0.022
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
35 |
0.022
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.022
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.022
|
|
|
|
negative regulation of cysteine type endopeptidase activity
|
GO:2000117 |
22 |
0.022
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.022
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.022
|
|
|
|
regulation of cation channel activity
|
GO:2001257 |
22 |
0.021
|
|
|
|
mature dendritic cell differentiation
|
GO:0097029 |
3 |
0.021
|
|
|
|
positive regulation of cell substrate adhesion
|
GO:0010811 |
47 |
0.021
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.021
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.021
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.021
|
|
|
|
acetate ester transport
|
GO:1901374 |
2 |
0.021
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.021
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.021
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.021
|
|
|
|
microglia development
|
GO:0014005 |
2 |
0.020
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.020
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.020
|
|
|
|
organ regeneration
|
GO:0031100 |
2 |
0.020
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.020
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.020
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.020
|
|
|
|
leukotriene production involved in inflammatory response
|
GO:0002540 |
2 |
0.019
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.019
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.019
|
|
|
|
response to amino acid
|
GO:0043200 |
37 |
0.019
|
|
|
|
response to water deprivation
|
GO:0009414 |
1 |
0.019
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.019
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.019
|
|
|
|
response to hepatocyte growth factor
|
GO:0035728 |
2 |
0.019
|
|
|
|
intestinal cholesterol absorption
|
GO:0030299 |
5 |
0.019
|
|
|
|
heart contraction
|
GO:0060047 |
93 |
0.019
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.019
|
|
|
|
maintenance of apical basal cell polarity
|
GO:0035090 |
3 |
0.019
|
|
|
|
positive regulation of angiogenesis
|
GO:0045766 |
46 |
0.019
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.019
|
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.018
|
|
|
|
positive regulation of adherens junction organization
|
GO:1903393 |
5 |
0.018
|
|
|
|
multicellular organismal reproductive behavior
|
GO:0033057 |
23 |
0.018
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.018
|
|
|
|
extracellular fibril organization
|
GO:0043206 |
2 |
0.018
|
|
|
|
cardiac muscle cell differentiation
|
GO:0055007 |
69 |
0.018
|
|
|
|
regulation of coagulation
|
GO:0050818 |
31 |
0.018
|
|
|
|
microglia differentiation
|
GO:0014004 |
2 |
0.018
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.018
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.018
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.018
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.018
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.018
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
68 |
0.018
|
|
|
|
entry into cell of other organism involved in symbiotic interaction
|
GO:0051806 |
15 |
0.017
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.017
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.017
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.017
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.017
|
|
|
|
response to water
|
GO:0009415 |
1 |
0.017
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.017
|
|
|
|
regulation of mitochondrion organization
|
GO:0010821 |
27 |
0.017
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.017
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.017
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.016
|
Rat |
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.016
|
|
|
|
cd4 positive alpha beta t cell cytokine production
|
GO:0035743 |
4 |
0.016
|
|
|
|
regulation of t cell apoptotic process
|
GO:0070232 |
28 |
0.016
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.016
|
|
|
|
negative regulation of coagulation
|
GO:0050819 |
11 |
0.016
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.016
|
|
|
|
regulation of the force of heart contraction
|
GO:0002026 |
17 |
0.016
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.016
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.016
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.016
|
|
|
|
neutrophil activation
|
GO:0042119 |
9 |
0.016
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.016
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.015
|
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
34 |
0.015
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.015
|
|
|
|
mononuclear cell migration
|
GO:0071674 |
8 |
0.015
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.015
|
|
|
|
myelination
|
GO:0042552 |
74 |
0.015
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.015
|
|
|
|
water homeostasis
|
GO:0030104 |
27 |
0.015
|
|
|
|
response to antibiotic
|
GO:0046677 |
11 |
0.015
|
|
|
|
regulation of calcium ion transmembrane transporter activity
|
GO:1901019 |
20 |
0.015
|
|
|
|
acid secretion
|
GO:0046717 |
33 |
0.015
|
|
|
|
positive regulation of focal adhesion assembly
|
GO:0051894 |
5 |
0.015
|
|
|
|
negative regulation of t cell receptor signaling pathway
|
GO:0050860 |
13 |
0.015
|
|
|
|
myeloid leukocyte activation
|
GO:0002274 |
83 |
0.015
|
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.015
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.015
|
|
|
|
forebrain radial glial cell differentiation
|
GO:0021861 |
4 |
0.014
|
|
|
|
prostate gland morphogenesis
|
GO:0060512 |
32 |
0.014
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.014
|
|
|
|
myofibril assembly
|
GO:0030239 |
34 |
0.014
|
|
|
|
regulation of transcription by galactose
|
GO:0000409 |
1 |
0.014
|
|
|
|
neuroblast proliferation
|
GO:0007405 |
49 |
0.014
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.014
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.014
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.014
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.014
|
|
|
|
astrocyte cell migration
|
GO:0043615 |
3 |
0.014
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.014
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
88 |
0.014
|
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.014
|
|
|
|
positive regulation of transmembrane transport
|
GO:0034764 |
29 |
0.014
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.014
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.014
|
|
|
|
regulation of stress fiber assembly
|
GO:0051492 |
15 |
0.014
|
|
|
|
arachidonic acid metabolite production involved in inflammatory response
|
GO:0002538 |
2 |
0.014
|
|
|
|
regulation of myeloid cell apoptotic process
|
GO:0033032 |
19 |
0.014
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.014
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.014
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.013
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.013
|
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.013
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.013
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.013
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
35 |
0.013
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.013
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.013
|
|
|
|
monocyte chemotaxis
|
GO:0002548 |
5 |
0.013
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.013
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.013
|
|